Press releases

Suspending the medical device tax will allow the industry to reinvest in work to benefit patients

Millipede, Inc. is developing the IRIS Transcatheter Annuloplasty Ring System to treat severe mitral regurgitation

Boston Scientific will webcast its conference call discussing Q4 financial results and business highlights on Feb. 1, 2018 at the updated time of 7:30 a.m. EST.

Randomized controlled trial demonstrates effectiveness of long-term treatment with sub-perception spinal cord stimulation

System offers non-opioid treatment option with multiple therapies for people with chronic pain

Based upon preliminary unaudited financial information, the company generated approximately $2.41 billion in sales during Q4 2017.

Boston Scientific will participate in the upcoming healthcare conference on Jan. 9, 2018. A live webcast and replay will be available.

Boston Scientific will participate in the healthcare conference on Jan. 4, 2018. A live webcast and replay will be available.

DBS platform offers physicians advanced technology to treat symptoms of Parkinson's disease

Boston Scientific will participate in the healthcare conference on December 14, 2017. A live webcast and replay will be available.

Company announces delay for commercialization of the LOTUS Edge™ Aortic Valve System in Europe and the U.S.

Boston Scientific will participate in the healthcare conference on December 7, 2017. A live webcast and replay will be available.

Boston Scientific will participate in the healthcare conference on Nov. 28, 2017. A live webcast and replay will be available.

American Heart Association, American College of Cardiology and Heart Rhythm Society issue updated guidelines underscoring benefits of the S-ICD system

Boston Scientific will participate in the Stifel 2017 Healthcare Conference on November 14, 2017.

Boston Scientific will participate in the conference on November 7, 2017.

Late-breaking data presented at TCT 2017 with simultaneous publication in the Journal of the American College of Cardiology

“We continue to invest in a deep and innovative portfolio and expand into faster-growing markets," said CEO Mike Mahoney.

Key data presented will include five-year outcomes for the WATCHMAN device as an alternative to long-term warfarin therapy for patients with non-valvular Afib.

CEO Mike Mahoney welcomed Ralls-Morrison as “an accomplished leader with deep expertise in broad-ranging legal matters and enterprise business strategy.”

Acquisition to strengthen company's electrophysiology portfolio

Company will webcast its conference call with financial results and business highlights for Q3 ended September 30, 2017.

HeartLogic is the first and only heart failure diagnostic in an implantable device shown to provide weeks of advance notice of an impending heart failure event.

Data presented demonstrate alert improves heart failure risk prediction

Boston Scientific (NYSE: BSX) today announced results from a three year follow-up cohort in its Post-FDA Approval Clinical Trial Evaluating Bronchial Thermoplasty (BT) in Severe Persistent Asthma...

Boston Scientific will participate in the Morgan Stanley healthcare conference on Sept. 12, 2017. Learn how to watch the webcast or replay.

Boston Scientific will participate in the healthcare conference on September 7, 2017. Learn how to watch the webcast or replay.

Boston Scientific will participate in the investor conference on August 9, 2017. Learn how to watch the webcast or replay.

"Our strong financial performance in the first half of 2017 reflects our innovative portfolio,” said CEO Mike Mahoney.

Boston Scientific will webcast its conference call with financial results for Q2 ended June 30, 2017. Learn how to tune in or watch the replay.

Investor meeting will cover Boston Scientific’s business and long-term growth strategies, including by expanding category leadership and driving global growth.

Industry's first MR-conditional directional DBS System with stimulation visualization

Results from evaluation of real-world patients presented at American Thoracic Society International Conference

Boston Scientific will participate in the healthcare conference on May 23, 2017. Learn how to watch the webcast or replay.

The first head-to-head pivotal study comparing two different TAVI platforms demonstrated the LOTUS™ Valve System’s superior efficacy.

BAcquisition expands company's structural heart portfolio; increases offerings for the treatment of patients with valvular heart disease

Largest prospective study of the WATCHMAN device presented as late-breaking trial at Heart Rhythm 2017

Analyses evaluated the impact of ethnicity, gender and income on cardiovascular outcomes

Late-breaker data presented at Heart Rhythm 2017

Pivotal data from REPRISE III and EWOLUTION among four late-breaking clinical trials to be presented

New devices combine longest-lasting battery technology, therapy optimization and HeartLogic™ heart failure diagnostics

Late-breaking clinical trials feature subcutaneous implantable defibrillator (S-ICD) and WATCHMAN™ left atrial appendage closure device

Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2017 Healthcare Conference on Thursday, May 18, 2017 in Las Vegas. Susie Lisa, vice...

"We are pleased with our performance in the first quarter,” said CEO Mike Mahoney

MADIT S-ICD trial to study EMBLEM™ MRI S-ICD System; part of pilot initiative to increase percentage of females enrolled in clinical studies

Boston Scientific will webcast both its Investor Day meeting and its conference call with financial results for Q1 ended March 31, 2017. Learn how to tune in.

Acquisition will expand treatments for patients with valvular heart disease and strengthen company's position in structural heart globally

Extended battery life of Boston Scientific devices attributed to reduction in replacement procedures and complications; potential for significant cost savings

Edwards found to infringe on Boston Scientific patents in Germany and U.K.

Boston Scientific will participate in the healthcare conference on March 15, 2017. A live webcast and replay will be available.